Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation

BACKGROUND: Cisplatin is a vital chemotherapy regimen for gastric cancer (GC), while partial response is observed (approximately 40%) because of drug resistance. Thus, it is urgent to improve drug sensitivity to improve the therapeutic effect of cisplatin on GC. PURPOSE: The study was performed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhipeng, Lin, Sihao, Wu, Xiaofang, Xu, Jiuhua, Li, Lulu, Ye, Weipeng, Li, Jiayi, Huang, Zhengjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837578/
https://www.ncbi.nlm.nih.gov/pubmed/33519210
http://dx.doi.org/10.2147/OTT.S276168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837578/
https://www.ncbi.nlm.nih.gov/pubmed/33519210
http://dx.doi.org/10.2147/OTT.S276168

Ejemplares similares